News >

Immunotherapy Lessons Learned in Melanoma May Turn Tide in Other Tumors

Brandon Scalea
Published: Wednesday, May 22, 2019

Adil Daud, MD
Adil Daud, MD
The use of immunotherapy in cancer was solidified by the ample activity seen in patients with melanoma, said Adil Daud, MD. Nevertheless, a better understanding of the biology driving this benefit may help expand the reach of this therapy into those with less immunogenic tumors.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Melanoma: Exploring BRAF/MEK in Adjuvant and Neoadjuvant SettingsSep 28, 20191.5
Medical Crossfire®: What Does Data Tell Us About How to Optimize Checkpoint Inhibitor Strategies Across Lines of Care for Patients with Melanoma?Nov 30, 20191.5
Publication Bottom Border
Border Publication
x